New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells
Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ)... read more
October 13, 2021
Tagged: Temozolomide
Behind the Study: Extending Survival in Glioma Models
Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more
May 10, 2021